glypican Antibodies

Santa Cruz Biotechnology features a diverse variety of glypican monoclonal antibodies for investigating glypicans in various biological processes. glypican Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glypicans are a family of heparan sulfate proteoglycans that influence cell signaling, growth regulation, and development. Through modulation of signaling pathways related to growth factors and morphogens, glypicans maintain proper cellular function and tissue homeostasis. Abnormal glypican expression has been linked to several diseases, including cancer, highlighting their significance as potential biomarkers and therapeutic targets. Glypican research continues to reveal new insights into cellular communication and disease mechanisms. Understanding glypican function and regulation advances knowledge in developmental biology and pathology. Current studies focus on how glypicans coordinate multiple signaling pathways and influence cell behavior. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of glypican biology and disease mechanisms.